Preventive Effect of Trimetazidine on Contrast Induced Nephropathy

Preventive Effect of Trimetazidine on Contrast Induced Nephropathy in CKD Patients Underwent Elective Coronary Angiography.3

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171004036555N1

Enrollment

100

Registered

2018-04-22

Start date

2016-02-20

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast Induced Nephropathy (CIN). Nephropathy induced by other drugs, medicaments and biological substances

Interventions

Intervention 1: Intervention group: The intervention group includes patients who are candidates for elective coronary angiography, and will be treated with normal saline 1 ml/kg/ hour from 12 hours be

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 30==45% candidate for Elective Coronary Angiography

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Percentage of patients with Contrast Induced Nephropathy (CIN). Timepoint: - creatinine measurement before intervention and 24,48 hours after intervention; NGAL(Neutrophil gelatinase-associated Lipocalin) before intervention and 12 hours after intervention. Method of measurement: -creatinine assay kit; NGAL assay kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirhossein Mirhosseini

Iran University of Medical Sciences

mirhosseini.a@iums.ac.ir+98 21 8670 1021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026